184 related articles for article (PubMed ID: 12011212)
1. Adenovirus gene therapy for ovarian cancer.
Russell W
J Natl Cancer Inst; 2002 May; 94(10):706-7. PubMed ID: 12011212
[No Abstract] [Full Text] [Related]
2. In vivo molecular chemotherapy and noninvasive imaging with an infectivity-enhanced adenovirus.
Hemminki A; Zinn KR; Liu B; Chaudhuri TR; Desmond RA; Rogers BE; Barnes MN; Alvarez RD; Curiel DT
J Natl Cancer Inst; 2002 May; 94(10):741-9. PubMed ID: 12011224
[TBL] [Abstract][Full Text] [Related]
3. An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression.
Hemminki A; Belousova N; Zinn KR; Liu B; Wang M; Chaudhuri TR; Rogers BE; Buchsbaum DJ; Siegal GP; Barnes MN; Gomez-Navarro J; Curiel DT; Alvarez RD
Mol Ther; 2001 Sep; 4(3):223-31. PubMed ID: 11545613
[TBL] [Abstract][Full Text] [Related]
4. A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway.
Tsuruta Y; Pereboeva L; Glasgow JN; Rein DT; Kawakami Y; Alvarez RD; Rocconi RP; Siegal GP; Dent P; Fisher PB; Curiel DT
Clin Cancer Res; 2007 May; 13(9):2777-83. PubMed ID: 17473211
[TBL] [Abstract][Full Text] [Related]
5. Growth suppression of human ovarian cancer cells by adenovirus-mediated transfer of the PTEN gene.
Minaguchi T; Mori T; Kanamori Y; Matsushima M; Yoshikawa H; Taketani Y; Nakamura Y
Cancer Res; 1999 Dec; 59(24):6063-7. PubMed ID: 10626791
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo.
Saito Y; Swanson X; Mhashilkar AM; Oida Y; Schrock R; Branch CD; Chada S; Zumstein L; Ramesh R
Gene Ther; 2003 Nov; 10(23):1961-9. PubMed ID: 14528320
[TBL] [Abstract][Full Text] [Related]
7. Strategies to adapt adenoviral vectors for targeted delivery.
O'Riordan CR; Song A; Lanciotti J
Methods Mol Med; 2003; 76():89-112. PubMed ID: 12526160
[No Abstract] [Full Text] [Related]
8. Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiation.
Rosser CJ; Tanaka M; Pisters LL; Tanaka N; Levy LB; Hoover DC; Grossman HB; McDonnell TJ; Kuban DA; Meyn RE
Cancer Gene Ther; 2004 Apr; 11(4):273-9. PubMed ID: 14765130
[TBL] [Abstract][Full Text] [Related]
9. Suppression of ovarian cancer growth via systemic administration with liposome-encapsulated adenovirus-encoding endostatin.
Yang L; Wang L; Su XQ; Wang L; Chen XC; Li D; Luo ST; Shi HS; Chen LJ; Wang YS
Cancer Gene Ther; 2010 Jan; 17(1):49-57. PubMed ID: 19609295
[TBL] [Abstract][Full Text] [Related]
10. Suppression of gastric cancer growth by adenovirus-mediated transfer of the PTEN gene.
Hang Y; Zheng YC; Cao Y; Li QS; Sui YJ
World J Gastroenterol; 2005 Apr; 11(15):2224-9. PubMed ID: 15818730
[TBL] [Abstract][Full Text] [Related]
11. In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity to doxorubicin.
Tanaka M; Grossman HB
Gene Ther; 2003 Sep; 10(19):1636-42. PubMed ID: 12923562
[TBL] [Abstract][Full Text] [Related]
12. Beyond p53.
Yeatman TJ
Ann Surg Oncol; 2003 Oct; 10(8):831. PubMed ID: 14527897
[No Abstract] [Full Text] [Related]
13. PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway.
Yuan XJ; Whang YE
Oncogene; 2002 Jan; 21(2):319-27. PubMed ID: 11803475
[TBL] [Abstract][Full Text] [Related]
14. Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells.
Davies MA; Kim SJ; Parikh NU; Dong Z; Bucana CD; Gallick GE
Clin Cancer Res; 2002 Jun; 8(6):1904-14. PubMed ID: 12060635
[TBL] [Abstract][Full Text] [Related]
15. PTEN decreases in vivo vascularization of experimental gliomas in spite of proangiogenic stimuli.
Abe T; Terada K; Wakimoto H; Inoue R; Tyminski E; Bookstein R; Basilion JP; Chiocca EA
Cancer Res; 2003 May; 63(9):2300-5. PubMed ID: 12727853
[TBL] [Abstract][Full Text] [Related]
16. [Characterization of TP53, APC, and PTEN mutational statuses of 120 human cancer cell lines by using yeast-based analyses].
Suzuki G
Hokkaido Igaku Zasshi; 2003 Sep; 78(5):437-49. PubMed ID: 14531287
[No Abstract] [Full Text] [Related]
17. Adenovirus-mediated intraarterial delivery of PTEN inhibits neointimal hyperplasia.
Huang J; Niu XL; Pippen AM; Annex BH; Kontos CD
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):354-8. PubMed ID: 15569824
[TBL] [Abstract][Full Text] [Related]
18. Current developments in adenovirus-based cancer gene therapy.
Rein DT; Breidenbach M; Curiel DT
Future Oncol; 2006 Feb; 2(1):137-43. PubMed ID: 16556080
[TBL] [Abstract][Full Text] [Related]
19. PTEN and p53: who will get the upper hand?
Trotman LC; Pandolfi PP
Cancer Cell; 2003 Feb; 3(2):97-9. PubMed ID: 12620402
[No Abstract] [Full Text] [Related]
20. PTEN gene therapy induces growth inhibition and increases efficacy of chemotherapy in prostate cancer.
Tanaka M; Rosser CJ; Grossman HB
Cancer Detect Prev; 2005; 29(2):170-4. PubMed ID: 15829377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
